Tumor-related and treatment-related colostomy-free survival (CFS) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA): Results of ACT II.
Robert Glynne-Jones
No relevant relationships to disclose
Latha Kadalayil
No relevant relationships to disclose
Helen Meadows
No relevant relationships to disclose
David Cunningham
No relevant relationships to disclose
Leslie M. Samuel
No relevant relationships to disclose
Ian Geh
Consultant or Advisory Role - Roche
Honoraria - Merck; Novartis; Sanofi
Charles Lowdell
No relevant relationships to disclose
Roger David James
No relevant relationships to disclose
Sandy Beare
No relevant relationships to disclose
Rubina Begum
No relevant relationships to disclose
Jonathan A. Ledermann
No relevant relationships to disclose
David Sebag-Montefiore
No relevant relationships to disclose